2015
Expertise vs Evidence in Assessment of Breast Biopsies: An Atypical Science
Davidson NE, Rimm DL. Expertise vs Evidence in Assessment of Breast Biopsies: An Atypical Science. JAMA 2015, 313: 1109-1110. PMID: 25781438, DOI: 10.1001/jama.2015.1945.Peer-Reviewed Original Research
2014
Automated Objective Determination of Percentage of Malignant Nuclei for Mutation Testing
Viray H, Coulter M, Li K, Lane K, Madan A, Mitchell K, Schalper K, Hoyt C, Rimm DL. Automated Objective Determination of Percentage of Malignant Nuclei for Mutation Testing. Applied Immunohistochemistry & Molecular Morphology 2014, 22: 363-371. PMID: 24162261, PMCID: PMC3999345, DOI: 10.1097/pai.0b013e318299a1f6.Peer-Reviewed Original ResearchConceptsCriterion standardMalignant cellsMalignant nucleiCompanion diagnostic testsTumor cell percentageMutation testingEosin-stained tissuesCell percentageInForm softwareHistologic specimensTumor tissueColon adenocarcinomaTumor cellsDiagnostic testsPotential future toolDNA mutation testingTissue sectionsContinuous variablesFurther validationPathologist estimationAnalytic sensitivityVariant resultsDNA mutationsBenign nucleiTissue
2011
Breast Cancer Misclassification: A Major Obstacle to Treatment?
Romeo E, Gustavson MD, Rimm DL. Breast Cancer Misclassification: A Major Obstacle to Treatment? Women's Health 2011, 7: 615-618. PMID: 22040201, DOI: 10.2217/whe.11.69.Peer-Reviewed Original Research